DR. PATRICK W SLATER, M.D.
Medical Practice in Austin, TX

2013010, May 2, 2013

Oct 31, 2012

13/665862

Patrick Slater - Austin TX, US

G02C 7/02

35115978

A method for treating a patient having a vestibular malady is provided. The method comprises (a) diagnosing the patient as having a vestibular malady; and (b) prescribing eyewear to the patient as a treatment of the vestibular malady, either alone or in conjunction with undertaking vestibular rehabilitation while wearing the eyewear. The eyewear () has a first lens () which extends over the field of vision of a first eye, wherein the first lens has first () and second () distinct optical regions. The eyewear imparts vision to the first eye which is characterized by a central vision having a first optical quality and a peripheral vision having a second optical quality.

7981104, Jul 19, 2011

Jan 25, 2005

11/042542

Patrick Slater - Austin TX, US

A61M 31/00

604514

A device is provided herein for the treatment of otitis externa. The device () comprises a receptacle () adapted to store a pharmaceutical composition, and a distal portion (), in open communication with the receptacle, which is adapted to apply the composition disposed in the receptacle to the meatal tissues of the external ear. A pharmaceutical composition is disposed in the receptacle, and comprises a corticosteroid disposed in a viscous medium. Preferably, the receptacle is charged with a single high dosage of the corticosteroid.

8337481, Dec 25, 2012

Jun 8, 2011

13/155706

Patrick Slater - Austin TX, US

A61M 31/00

604514

A method is provided for treating swimmer's ear and other types of otitis externa. The method comprises (a) diagnosing an instance of swimmer's ear in a patient; and (b) applying to the meatal tissues of the external ear of the patient, in a single application, a volume of a pharmaceutical composition preferably within the range of about 0. 1 ml to about 1. 5 ml. The pharmaceutical composition comprises a corticosteroid disposed in a viscous medium, and preferably also includes an antifungal agent. The corticosteroid is preferably betamethasone or a betamethasone derivative, and the concentration of the corticosteroid is preferably within the range of about 0. 45 mg to about 0. 9 mg per gram of the pharmaceutical composition.

2013005, Feb 28, 2013

Aug 31, 2012

13/601784

Patrick Slater - Austin TX, US

H04R 25/00

381317

A hearing aid is provided which includes (a) a receiver section equipped with a receiver; (b) a lateral section equipped with a microphone and a battery; (c) a sealing retainer concentrically positioned over said receiver section which conforms to the walls at the bony region of the ear canal, thereby seating the hearing device in the ear canal and providing acoustical sealing against feedback within the ear canal; and (d) a circuit which dampens or suppresses at least a portion of the acoustical footprint of a threshold event, or which deactivates the hearing aid for a time interval in response to a threshold event.

2013005, Feb 28, 2013

Aug 24, 2012

13/594505

Patrick Slater - Austin TX, US

A63B 69/00

473422

A method for training an athlete is provided. The method includes equipping the athlete with eyewear having a first lens () which extends over the field of vision of a first eye, wherein the first lens has first () and second () distinct optical regions which impart vision to the first eye which is characterized by undistorted central vision and distorted peripheral vision; and causing the athlete to undertake a training exercise which replicates a motion required by the sport the athlete is being trained for.